Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liposarcoma,Myxoid”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367
What this trial is testing

Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)UnknownNCT03816475
What this trial is testing

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)

Who this might be right for
Myxoid Liposarcoma
Maria Sklodowska-Curie National Research Institute of Oncology 35
Early research (Phase 1)Study completedNCT01477021
What this trial is testing

Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult LiposarcomaAdult Synovial SarcomaRecurrent Adult Soft Tissue Sarcoma+2 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT02609984
What this trial is testing

Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)

Who this might be right for
SarcomaMyxoid/Round Cell LiposarcomaSynovial Sarcoma+4 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 89
Testing effectiveness (Phase 2)Study completedNCT04794127
What this trial is testing

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.

Who this might be right for
Liposarcoma, MyxoidLiposarcoma, DedifferentiatedLiposarcoma, Round Cell
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Looking for participantsNCT06843967
What this trial is testing

Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Who this might be right for
Well Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more
Memorial Sloan Kettering Cancer Center 54
Large-scale testing (Phase 3)Study completedNCT00346164
What this trial is testing

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+26 more
Children's Oncology Group 588
Very early researchLooking for participantsNCT07261657
What this trial is testing

N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaSynovial Sarcoma
Seth Pollack 8
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05266196
What this trial is testing

A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)

Who this might be right for
Ewing SarcomaMyxoid LiposarcomaDesmoplastic Small Round Cell Tumor+6 more
Salarius Pharmaceuticals, LLC 10
Early research (Phase 1)Ended earlyNCT03399448
What this trial is testing

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Who this might be right for
Multiple MyelomaMelanomaSynovial Sarcoma+1 more
University of Pennsylvania 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)UnknownNCT04356872
What this trial is testing

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Fudan University 45
Testing effectiveness (Phase 2)WithdrawnNCT03397186
What this trial is testing

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Who this might be right for
Myxoid LiposarcomaRound Cell LiposarcomaStage III Soft Tissue Sarcoma AJCC v7+3 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT03450122
What this trial is testing

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Myxoid Liposarcoma+1 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Not Yet RecruitingNCT06748872
What this trial is testing

EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma

Who this might be right for
Epithelial Ovarian CancerGastro-esophageal Junction CancerSoft Tissue Sarcoma (STS)+2 more
Medigene AG 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Next Page